SHG Provides Compensation Analysis to GB Sciences, Inc.
SHG is pleased to announce it has completed a detailed compensation analysis for GB Sciences, Inc., for the benefit of attracting and retaining the senior leadership team. Our analysis was used among management and its advisors.
About GB Sciences, Inc.
GB Sciences is a biopharmaceutical and cannabinoid-based drug development company whose goal is to create patented formulations for safe, standardized, cannabinoid therapies that target a variety of medical conditions in both the pharmaceutical and wellness markets. To learn more about GB Sciences please visit Home - GB Sciences.
See how iSimulate found the right growth partner with SHG. Learn how a focused M&A process secured a strategic exit to 3B Scientific for global scale.
Maximize value by planning your exit 3-5 years early. Learn key benchmarks to reduce founder dependency and prepare for a successful sale.
